• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.

作者信息

Prajna Venkatesh N, Lalitha Prajna S, Mascarenhas Jeena, Krishnan Tiruvengada, Srinivasan Muthiah, Vaitilingam C M, Oldenburg Catherine E, Sy Aileen, Keenan Jeremy David, Porco Travis C, Acharya Nisha R, Lietman Thomas M

出版信息

Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.

DOI:10.1136/bjophthalmol-2012-301825
PMID:22914503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3833089/
Abstract
摘要

相似文献

1
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.那他霉素和伏立康唑治疗镰刀菌和曲霉菌角膜炎：一项随机对照试验的亚组分析
Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.
2
Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.真菌性角膜炎病原菌及致病真菌对治疗药物的纸片扩散法药敏研究
Curr Eye Res. 2015;40(11):1095-101. doi: 10.3109/02713683.2015.1056802. Epub 2015 Aug 13.
3
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.真菌性溃疡治疗试验I中抗真菌药物预处理与真菌耐药性的关联。
JAMA Ophthalmol. 2015 Oct;133(10):1210-1. doi: 10.1001/jamaophthalmol.2015.2040.
4
Benefit of polyhexamethylene biguanide in Fusarium keratitis.聚六亚甲基双胍在镰刀菌角膜炎中的益处。
Ophthalmic Res. 2012;48(4):171-6. doi: 10.1159/000337140. Epub 2012 Jun 16.
5
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.《Mycotic Ulcer Treatment Trial I 专家先验 elicitation 和贝叶斯分析》。
Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716.
6
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.伏立康唑口服辅助治疗镰刀菌角膜炎：真菌性溃疡治疗试验II的二次分析
JAMA Ophthalmol. 2017 Jun 1;135(6):520-525. doi: 10.1001/jamaophthalmol.2017.0616.
7
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis.伏立康唑用于治疗难治性烟曲霉角膜炎。
Indian J Ophthalmol. 2008 May-Jun;56(3):243-5. doi: 10.4103/0301-4738.40369.
8
Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of and Isolates from Corneal Scrapings.真菌性角膜炎：角膜刮片分离的 和 菌株的流行病学、快速检测和抗真菌药敏性。
Biomed Res Int. 2019 Jan 20;2019:6395840. doi: 10.1155/2019/6395840. eCollection 2019.
9
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.兔 Fusarium 角膜炎中局部伏立康唑 1%和基质内伏立康唑 0.05%与局部那他霉素 5%单药治疗的治疗反应时间。
Mycoses. 2020 Oct;63(10):1128-1132. doi: 10.1111/myc.13160. Epub 2020 Sep 4.
10
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.真菌性溃疡治疗试验：一项比较那他霉素与伏立康唑的随机试验。
JAMA Ophthalmol. 2013 Apr;131(4):422-9. doi: 10.1001/jamaophthalmol.2013.1497.

引用本文的文献

1
kexB Gene Correlates With Aspergillus flavus Keratitis Severity: A Whole-Genome Analysis.kexB基因与黄曲霉角膜炎严重程度相关：全基因组分析
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):42. doi: 10.1167/iovs.66.2.42.
2
Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control.引起角膜炎的镰刀菌属的抗真菌药敏性、临床特征及生物膜耐药性：疾病控制面临的一项挑战
Braz J Microbiol. 2025 Mar;56(1):341-352. doi: 10.1007/s42770-024-01611-8. Epub 2025 Jan 16.
3
Association between in vitro susceptibility and clinical outcomes in fungal keratitis.真菌性角膜炎的体外药敏与临床结局之间的关联。
J Ophthalmic Inflamm Infect. 2024 Sep 2;14(1):42. doi: 10.1186/s12348-024-00418-w.
4
Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.镰刀菌属、枝顶孢属和繁茂枝孢菌：为世界卫生组织真菌病原体优先排序提供信息的系统综述。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad128.
5
Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical Features.台湾地区的角膜炎：分子鉴定、抗真菌药敏性及临床特征
J Fungi (Basel). 2022 May 3;8(5):476. doi: 10.3390/jof8050476.
6
Keratitis-Review of Current Treatment Possibilities.角膜炎——当前治疗方法综述
J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468.
7
Drug reservoir function of voriconazole impregnated human amniotic membrane: An study.载有伏立康唑的人羊膜的药物储存功能：一项研究。
Indian J Ophthalmol. 2021 May;69(5):1068-1072. doi: 10.4103/ijo.IJO_2649_20.
8
Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.卢立康唑对包括引起真菌性角膜炎的茄病镰刀菌种复合体在内的多种丝状真菌的疗效。
Cornea. 2019 Feb;38(2):238-242. doi: 10.1097/ICO.0000000000001812.
9
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.真菌性角膜炎治疗实践模式的演变
JAMA Ophthalmol. 2017 Dec 1;135(12):1448-1449. doi: 10.1001/jamaophthalmol.2017.4763.
10
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.曲霉病诊断和管理实践指南：美国感染病学会2016年更新版
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.

本文引用的文献

1
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.那他霉素与伏立康唑治疗真菌性角膜炎的比较。
Arch Ophthalmol. 2010 Jun;128(6):672-8. doi: 10.1001/archophthalmol.2010.102.
2
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.从角膜炎中分离出的镰刀菌、曲霉菌及其他丝状真菌的药敏性
Arch Ophthalmol. 2007 Jun;125(6):789-93. doi: 10.1001/archopht.125.6.789.
3
Voriconazole and fungal keratitis: a report of two treatment failures.伏立康唑与真菌性角膜炎：两例治疗失败报告
J Ocul Pharmacol Ther. 2006 Dec;22(6):437-9. doi: 10.1089/jop.2006.22.437.
4
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.伏立康唑对角膜炎和眼内炎真菌病原体敏感性的体外研究。
Am J Ophthalmol. 2004 May;137(5):820-5. doi: 10.1016/j.ajo.2003.11.078.
5
Current perspectives on ophthalmic mycoses.眼部真菌病的当前观点
Clin Microbiol Rev. 2003 Oct;16(4):730-97. doi: 10.1128/CMR.16.4.730-797.2003.